News & Media

All Resources
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Media Coverage
Media Coverage
December 7, 2023
2023
2023

UNITY Fetal Risk Screen has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.

Learn More
Media Coverage
December 7, 2023
2023
2023

UNITY Fetal Risk Screen has earned a spot in AJHG’s Genomic Medicine Year in Review: 2023, recognized as a top 10 key advancement in applying genomics to clinical care.

Learn More
Media Coverage
Media Coverage
December 5, 2023
2023
2023

BillionToOne recognized as one of the most promising digital health companies of 2023 by CB Insights

Learn More
Media Coverage
December 5, 2023
2023
2023

BillionToOne recognized as one of the most promising digital health companies of 2023 by CB Insights

Learn More
Press Releases
Press Releases
October 30, 2023
2023
2023

BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population

Learn More
Press Releases
October 30, 2023
2023
2023

BillionToOne Announces Clinical Outcomes Data for UNITY Fetal Risk™ Screen, Demonstrating Exceptional Accuracy in General Pregnancy Population

Learn More
Press Releases
Press Releases
August 11, 2023
2023
2023

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

Learn More
Press Releases
August 11, 2023
2023
2023

BillionToOne Publishes UNITY Fetal RhD and Fetal Antigen NIPT Clinical Validity Demonstrating >99.9% Accuracy

Learn More
Media Coverage
Media Coverage
May 1, 2023
2023
2023

BillionToOne, Inc., Secures Landmark Win in Lawsuit Against CDPH’s PNS Program in Order to Maintain Patient and Provider Choice Regarding Cell-free DNA Screening for Trisomy 21, 18, and 13

Learn More
Media Coverage
May 1, 2023
2023
2023

BillionToOne, Inc., Secures Landmark Win in Lawsuit Against CDPH’s PNS Program in Order to Maintain Patient and Provider Choice Regarding Cell-free DNA Screening for Trisomy 21, 18, and 13

Learn More
Press Releases
Press Releases
January 23, 2023
2023
2023

BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

Learn More
Press Releases
January 23, 2023
2023
2023

BillionToOne appoints Dr. Gary Palmer as Chief Medical Officer, Oncology; Launches Northstar Select™ and Northstar Response™ Liquid Biopsy Assays for Commercial Use

Learn More
Press Releases
Press Releases
December 16, 2022
2022
2022

BillionToOne Announces $48.5M Additional Capital Raise and $35M Upsized Term Loan Facility, Demonstrating Investor and Lender Confidence in the Company's Rapid Growth

Learn More
Press Releases
December 16, 2022
2022
2022

BillionToOne Announces $48.5M Additional Capital Raise and $35M Upsized Term Loan Facility, Demonstrating Investor and Lender Confidence in the Company's Rapid Growth

Learn More
Press Releases
Press Releases
December 6, 2022
2022
2022

BillionToOne Announces New Clinical Outcomes Data Showing High Sensitivity of UNITY Screen™ to Detect Pregnancies at Risk for Recessive Conditions

Learn More
Press Releases
December 6, 2022
2022
2022

BillionToOne Announces New Clinical Outcomes Data Showing High Sensitivity of UNITY Screen™ to Detect Pregnancies at Risk for Recessive Conditions

Learn More